These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Differentiation and Protective Capacity of Virus-Specific CD8 Tomov VT; Palko O; Lau CW; Pattekar A; Sun Y; Tacheva R; Bengsch B; Manne S; Cosma GL; Eisenlohr LC; Nice TJ; Virgin HW; Wherry EJ Immunity; 2017 Oct; 47(4):723-738.e5. PubMed ID: 29031786 [TBL] [Abstract][Full Text] [Related]
23. Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection. Blazevic V; Malm M; Vesikari T J Med Virol; 2015 Oct; 87(10):1656-61. PubMed ID: 25946711 [TBL] [Abstract][Full Text] [Related]
24. Noroviruses: epidemiology, immunity and prospects for prevention. Pringle K; Lopman B; Vega E; Vinje J; Parashar UD; Hall AJ Future Microbiol; 2015; 10(1):53-67. PubMed ID: 25598337 [TBL] [Abstract][Full Text] [Related]
25. Norovirus vaccines under development. Lucero Y; Vidal R; O'Ryan G M Vaccine; 2018 Aug; 36(36):5435-5441. PubMed ID: 28668568 [TBL] [Abstract][Full Text] [Related]
26. Antibody is critical for the clearance of murine norovirus infection. Chachu KA; Strong DW; LoBue AD; Wobus CE; Baric RS; Virgin HW J Virol; 2008 Jul; 82(13):6610-7. PubMed ID: 18417579 [TBL] [Abstract][Full Text] [Related]
27. Norovirus immunity and the great escape. Debbink K; Lindesmith LC; Donaldson EF; Baric RS PLoS Pathog; 2012; 8(10):e1002921. PubMed ID: 23093932 [No Abstract] [Full Text] [Related]
31. Understanding the relationship between norovirus diversity and immunity. Ford-Siltz LA; Tohma K; Parra GI Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33783322 [TBL] [Abstract][Full Text] [Related]
32. Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus. Liu G; Kahan SM; Jia Y; Karst SM J Virol; 2009 Jul; 83(13):6963-8. PubMed ID: 19403675 [TBL] [Abstract][Full Text] [Related]
33. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Nice TJ; Baldridge MT; McCune BT; Norman JM; Lazear HM; Artyomov M; Diamond MS; Virgin HW Science; 2015 Jan; 347(6219):269-73. PubMed ID: 25431489 [TBL] [Abstract][Full Text] [Related]
34. Enteric bacteria promote human and mouse norovirus infection of B cells. Jones MK; Watanabe M; Zhu S; Graves CL; Keyes LR; Grau KR; Gonzalez-Hernandez MB; Iovine NM; Wobus CE; Vinjé J; Tibbetts SA; Wallet SM; Karst SM Science; 2014 Nov; 346(6210):755-9. PubMed ID: 25378626 [TBL] [Abstract][Full Text] [Related]
35. Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013. Huhti L; Blazevic V; Puustinen L; Hemming M; Salminen M; Vesikari T Infect Genet Evol; 2014 Aug; 26():65-71. PubMed ID: 24837668 [TBL] [Abstract][Full Text] [Related]
36. Duration of immunity to norovirus gastroenteritis. Simmons K; Gambhir M; Leon J; Lopman B Emerg Infect Dis; 2013 Aug; 19(8):1260-7. PubMed ID: 23876612 [TBL] [Abstract][Full Text] [Related]
37. Chronic norovirus infection in primary immune deficiency disorders: an international case series. Rolfes MC; Sriaroon P; Dávila Saldaña BJ; Dvorak CC; Chapdelaine H; Ferdman RM; Chen K; Jolles S; Patel NC; Kim YJ; Tarrant TK; Martelius T; Seppanen M; Joshi AY Diagn Microbiol Infect Dis; 2019 Jan; 93(1):69-73. PubMed ID: 30174143 [TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and genetic diversity of noroviruses in adults with acute gastroenteritis in Beijing, China in 2008-2009. Tian G; Jin M; Li H; Li Q; Wang J; Duan ZJ J Med Virol; 2014 Jul; 86(7):1235-42. PubMed ID: 24523136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]